Klin Farmakol Farm. 2005;19(2):121-123

The role of lamotrigine in bipolar depression treatment

MUDr. Lívia Vavrušová
Psychiatrická klinika SPAM FN Ružinov, Bratislava

Anticonvulsants have assumed major importance in the treatment of bipolar disorder as mood stabilizers. Anticonvulsants are not a single therapeutic class, but are composed of multiple distinct subclasses with various mechanisms of action, efficacies, and side effects. Lamotrigine has found its place in the treatment of bipolar depression. International Consensus Group on Bipolar Depression Treatment Guidelines have confirmed lamotrigine to be the drug for treatment of bipolar depression with category 1 data.

Keywords: Key words: anticonvulsantsm, lamotrigine, bipolar depression.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vavrušová L. The role of lamotrigine in bipolar depression treatment. Klin Farmakol Farm. 2005;19(2):121-123.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Schatzberg AF, Nemeroff CB, eds. Textbook of Psychiatry, 3rd ed. Washington D.C., American Psychiatric Press, 2003.
    2. Gee NS, a kol. J. Biol. Cem. 1996; 271: 5768-5776. Go to original source...
    3. Stahl SM. Psychopharmacology of Anticolvunsants: Do all Anticonvulsants Have the same mechanism of Action?, J. Clin. Psychiatry, 65: 2, February, 2004: 149-150. Go to original source... Go to PubMed...
    4. International Consensus Group on Bipolar I Depression Treatment Guidelines, J. Clinical Psychiatry, 2004; 65: 1-9. Go to original source...
    5. Calabrese JR, Bowden CL, Sachs GS, a. kol. A double blind placebo controlled study of lamotrigine monotherapy in outpatients with bipolar I depression., J. Clin. Psychiatry, 1999; 60: 79-88. Go to original source... Go to PubMed...
    6. Calabrese JR, Bowden CL, Sachs G, a kol. A placebo controlled 18 month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar disorder., J. Clin. Psych., 2003; 64: 1013-1024. Go to original source... Go to PubMed...
    7. White HS. J. Clin. Psychiatry, 2003; 64: (Suppl. 8): 5-8.
    8. Tohen M, Vieta E, Calabrese J, a kol.: Efficacy of olanzapine and olanzapine - fluoxetine combination in the treatment of bipolar I depression. Arch. Gen. Psychiatry, 2003; 60: 1079-1088. Go to original source... Go to PubMed...
    9. Vavrušová L. Bipolárna depresia In: Vavrušová L. ed. Bipolárna porucha, Vydavateľstvo Osveta, Martin, 2004: 194-204.
    10. Češková E. Antikonvulziva v psychiatrii In Vavrušová L. ed. Bipolárna porucha, Vydavateľstvo Osveta, Martin, 2004; 114-129.

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.